The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Degenerative, ischemic, rheumatic and infectious (endocarditis) processes are responsible
for mitral valve disease in adults. Mitral valve repair has been widely regarded as the …

Mitral valve repair (MVRepair) has become the procedure of choice to correct severe
degenerative mitral regurgitation (MR), due to its documented superiority to valve …

Background Gender disparities in outcomes have been documented in cardiac surgery.
Gender differences in long-term survival after mitral valve operations, especially in the …

Background—The optimal treatment for ischemic mitral regurgitation remains actively
debated. Our objective was to evaluate the relationship between ischemic mitral …

This paper provides a review of engineering applications and computational methods used
to analyze the dynamics of heart valve closures in healthy and diseased states …

Objective We evaluated the combined effect of hospital and surgeon volume on operative
outcomes of mitral valve surgery in the United States. Methods The Nationwide Inpatient …

The short-term advantage of mitral valve repair versus replacement for degenerative
disease has been extensively documented. These advantages include lower operative …

Objective Patient selection for robotically assisted mitral valve repair remains controversial.
We assessed outcomes of a conservative screening algorithm developed to select patients …

Abstract OBJECTIVES Transapical Neochordae implantation (NC) allows beating heart
mitral valve repair in patients with degenerative mitral regurgitation. The aim of this single …